PLIVA 327 (Hydralazine 25 mg)

Pill imprint PLIVA 327 has been identified as Hydralazine hydrochloride 25 mg.

Hydralazine is used in the treatment of high blood pressure; hypertensive emergency; heart failure and belongs to the drug class vasodilators. Risk cannot be ruled out during pregnancy. Hydralazine 25 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for PLIVA 327

Hydralazine hydrochloride 25 mg PLIVA 327
Hydralazine hydrochloride 25 mg PLIVA 327
Hydralazine hydrochloride 25 mg PLIVA 327
Hydralazine hydrochloride 25 mg PLIVA 327  Front
Hydralazine hydrochloride 25 mg PLIVA 327  Back
Hydralazine hydrochloride
Imprint:
PLIVA 327
Strength:
25 mg
Color:
Orange
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Vasodilators
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals
National Drug Code (NDC):
50111-0327
Inactive Ingredients:
lactose anhydrous
FD&C Yellow No. 6
aluminum oxide
microcrystalline cellulose
sodium starch glycolate type A potato
stearic acid

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)